Aurdan Capital Management LLC Sells 3,636 Shares of UnitedHealth Group Incorporated $UNH

Aurdan Capital Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 22.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,210 shares of the healthcare conglomerate’s stock after selling 3,636 shares during the quarter. UnitedHealth Group makes up 1.3% of Aurdan Capital Management LLC’s holdings, making the stock its 17th biggest position. Aurdan Capital Management LLC’s holdings in UnitedHealth Group were worth $4,216,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Modus Advisors LLC increased its stake in shares of UnitedHealth Group by 14.2% during the 3rd quarter. Modus Advisors LLC now owns 3,724 shares of the healthcare conglomerate’s stock worth $1,286,000 after purchasing an additional 463 shares during the last quarter. Prasad Wealth Partners LLC acquired a new position in UnitedHealth Group during the third quarter worth approximately $662,000. Poehling Capital Management INC. acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $3,112,000. MONECO Advisors LLC increased its holdings in shares of UnitedHealth Group by 2.7% during the 3rd quarter. MONECO Advisors LLC now owns 4,130 shares of the healthcare conglomerate’s stock worth $1,426,000 after acquiring an additional 110 shares during the last quarter. Finally, Waterloo Capital L.P. lifted its holdings in UnitedHealth Group by 9.6% during the 3rd quarter. Waterloo Capital L.P. now owns 6,060 shares of the healthcare conglomerate’s stock valued at $2,093,000 after purchasing an additional 531 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analysts maintain a cautious bullish tilt: the street consensus is a “Moderate Buy,” reflecting continued confidence in UNH’s franchise despite recent volatility. UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Recommendation of “Moderate Buy” by Analysts
• Positive Sentiment: Mizuho lowered its price target (from $430 to $350) but kept an “outperform” stance, signaling the view that substantial upside still exists over time despite the near-term headwinds. Benzinga
• Positive Sentiment: Bullish commentators argue the selloff may be a buying opportunity, pointing to long-term growth, AI-driven cost initiatives, insider buying and the company’s historical ability to recover from setbacks. UnitedHealth: Buy The Dip As Multiple Factors Could Drive Strong Long-Term Returns
• Neutral Sentiment: Online interest in UNH has spiked, increasing trading attention and volatility — useful context for near-term flow-driven moves but not a fundamental change. Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
• Neutral Sentiment: Corporate PR note: UnitedHealth marketing chief Terry Clark was appointed CEO of the PGA of America — a non-material executive move that is unlikely to affect UNH fundamentals. Health care executive Terry Clark is appointed CEO at the PGA of America
• Negative Sentiment: Q4 results: UNH posted a modest EPS beat but revenue and margins disappointed; investors focused on a spike in medical costs and management’s cautious tone, which triggered a sharp selloff. UnitedHealth’s Q4 Beat Can’t Stop the Slide: Should You Let Go Now?
• Negative Sentiment: Regulatory risk intensified after reports of a DOJ probe and follow-up regulatory questions — adds execution and legal uncertainty that can pressure valuation multiples. UnitedHealth Group Faces DOJ Probe And Regulatory Questions For Future Returns
• Negative Sentiment: Broker and media pessimism is piling up: some firms issued more cautious forecasts and coverage highlighting margin risk and a revenue miss — reinforcing sell-side pressure. Truist Financial Issues Pessimistic Forecast for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $268.54 on Friday. The company’s 50 day simple moving average is $326.94 and its 200 day simple moving average is $323.01. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a market capitalization of $243.26 billion, a price-to-earnings ratio of 20.36, a price-to-earnings-growth ratio of 1.27 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.22 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same quarter last year, the company posted $6.81 EPS. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. cut their target price on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a research note on Monday. Weiss Ratings restated a “hold (c-)” rating on shares of UnitedHealth Group in a report on Wednesday, January 21st. UBS Group dropped their price target on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Barclays lowered their price objective on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Finally, Jefferies Financial Group decreased their price target on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.